speb/financial-data huggingface dataset:
ICU balance_sheet (annual, 2023-12-31) — Capital Stock: 1000.00
ICU balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 176000.00
ICU balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 176000.00
ICU balance_sheet (annual, 2023-12-31) — Cash Financial: 176000.00
ICU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 10414000.00
ICU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -10285000.00
ICU cash_flow (annual, 2023-12-31) — Change In Account Payable: 2445000.00
ICU cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 517000.00
ICU cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
ICU cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
ICU cash_flow (annual, 2023-12-31) — Change In Payable: 2445000.00
ICU cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2962000.00
ICU cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -97000.00
ICU cash_flow (annual, 2023-12-31) — Change In Receivables: 12000.00
ICU cash_flow (annual, 2023-12-31) — Change In Working Capital: 2877000.00
ICU cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 0.00
ICU cash_flow (annual, 2023-12-31) — Changes In Cash: 129000.00
ICU balance_sheet (annual, 2023-12-31) — Common Stock: 1000.00
ICU balance_sheet (annual, 2023-12-31) — Common Stock Equity: -13870000.00
ICU cash_flow (annual, 2023-12-31) — Common Stock Issuance: 6612000.00
ICU income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
ICU balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1523000.00
ICU balance_sheet (annual, 2023-12-31) — Current Assets: 2308000.00
ICU balance_sheet (annual, 2023-12-31) — Current Debt: 4744000.00
ICU balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4744000.00
ICU balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 100000.00
ICU balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 100000.00
ICU balance_sheet (annual, 2023-12-31) — Current Liabilities: 13046000.00
ICU income_statement (annual, 2023-12-31) — Diluted Average Shares: 86681.00
ICU income_statement (annual, 2023-12-31) — Diluted EPS: -302.60
ICU income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -26232000.00
ICU income_statement (annual, 2023-12-31) — EBIT: -25151000.00
ICU income_statement (annual, 2023-12-31) — EBITDA: -25151000.00
ICU cash_flow (annual, 2023-12-31) — End Cash Position: 176000.00
ICU cash_flow (annual, 2023-12-31) — Financing Cash Flow: 10414000.00
ICU cash_flow (annual, 2023-12-31) — Free Cash Flow: -10285000.00
ICU cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 763000.00
ICU income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -763000.00
ICU income_statement (annual, 2023-12-31) — General And Administrative Expense: 8237000.00
ICU income_statement (annual, 2023-12-31) — Gross Profit: 0.00
ICU cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
ICU income_statement (annual, 2023-12-31) — Interest Expense: 1081000.00
ICU income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 1081000.00
ICU income_statement (annual, 2023-12-31) — Interest Income: 0.00
ICU income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
ICU cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1126000.00
ICU balance_sheet (annual, 2023-12-31) — Interest Payable: 19000.00
ICU balance_sheet (annual, 2023-12-31) — Invested Capital: -4789000.00
ICU cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 6612000.00
ICU cash_flow (annual, 2023-12-31) — Issuance Of Debt: 8800000.00
ICU balance_sheet (annual, 2023-12-31) — Long Term Debt: 4337000.00
ICU balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4337000.00
ICU cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 8800000.00
ICU cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5270000.00
ICU cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 6612000.00
ICU balance_sheet (annual, 2023-12-31) — Net Debt: 8905000.00
ICU income_statement (annual, 2023-12-31) — Net Income: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -26232000.00
ICU cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -26232000.00
ICU income_statement (annual, 2023-12-31) — Net Interest Income: -1081000.00
ICU cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 3530000.00
ICU cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 3530000.00
ICU income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1081000.00
ICU cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -500000.00
ICU balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -13870000.00
ICU income_statement (annual, 2023-12-31) — Normalized EBITDA: -19439000.00
ICU income_statement (annual, 2023-12-31) — Normalized Income: -20520000.00
ICU cash_flow (annual, 2023-12-31) — Operating Cash Flow: -10285000.00
ICU cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5712000.00
ICU income_statement (annual, 2023-12-31) — Operating Income: -14210000.00
ICU income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
ICU balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 190461.00
ICU balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 4744000.00
ICU balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2307000.00
ICU income_statement (annual, 2023-12-31) — Other Gand A: 8237000.00
ICU income_statement (annual, 2023-12-31) — Other Income Expense: -10941000.00
ICU cash_flow (annual, 2023-12-31) — Other Non Cash Items: 48000.00
ICU balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1205000.00
ICU income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -5229000.00
ICU income_statement (annual, 2023-12-31) — Other Special Charges: 4949000.00
ICU balance_sheet (annual, 2023-12-31) — Payables: 4372000.00
ICU balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 5895000.00
ICU balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
ICU balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2132000.00
ICU income_statement (annual, 2023-12-31) — Pretax Income: -26232000.00
ICU cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 772000.00
ICU balance_sheet (annual, 2023-12-31) — Receivables: 0.00
ICU income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
ICU cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5270000.00
ICU income_statement (annual, 2023-12-31) — Research And Development: 5973000.00
ICU balance_sheet (annual, 2023-12-31) — Retained Earnings: -114734000.00
ICU income_statement (annual, 2023-12-31) — Selling General And Administration: 8237000.00
ICU balance_sheet (annual, 2023-12-31) — Share Issued: 190461.00
ICU income_statement (annual, 2023-12-31) — Special Income Charges: -4949000.00
ICU cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1930000.00
ICU balance_sheet (annual, 2023-12-31) — Stockholders Equity: -13870000.00
ICU balance_sheet (annual, 2023-12-31) — Tangible Book Value: -13870000.00
ICU income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (annual, 2023-12-31) — Tax Provision: 0.00
ICU income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ICU balance_sheet (annual, 2023-12-31) — Total Assets: 3513000.00
ICU balance_sheet (annual, 2023-12-31) — Total Capitalization: -9533000.00
ICU balance_sheet (annual, 2023-12-31) — Total Debt: 9081000.00
ICU balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -13870000.00
ICU income_statement (annual, 2023-12-31) — Total Expenses: 14210000.00
ICU balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 17383000.00
ICU balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1205000.00
ICU balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4337000.00
ICU income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -14210000.00
ICU income_statement (annual, 2023-12-31) — Total Unusual Items: -5712000.00
ICU income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -5712000.00
ICU cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 5380000.00
ICU balance_sheet (annual, 2023-12-31) — Working Capital: -10738000.00
ICU cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 0.00
ICU balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 550000.00
ICU balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 550000.00
ICU income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 192000.00
ICU balance_sheet (quarterly, 2024-09-30) — Interest Payable: 0.00
ICU cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
ICU cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: -3185000.00
ICU cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -3185000.00
ICU income_statement (quarterly, 2024-09-30) — Other Income Expense: 192000.00
ICU balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1184000.00
ICU income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
ICU income_statement (quarterly, 2024-09-30) — Total Unusual Items: 192000.00
ICU income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 192000.00
ICU cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
ICU income_statement (annual, 2024-12-31) — +Operating Expense: 17977000.00
ICU income_statement (annual, 2024-12-31) — +Total Revenue: 135000.00
ICU balance_sheet (annual, 2024-12-31) — Accounts Payable: 3046000.00
ICU balance_sheet (annual, 2024-12-31) — Accounts Receivable: 112000.00
ICU balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 137379000.00
ICU balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ICU balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
ICU income_statement (annual, 2024-12-31) — Basic Average Shares: 374355.00
ICU income_statement (annual, 2024-12-31) — Basic EPS: -66.30
ICU cash_flow (annual, 2024-12-31) — Beginning Cash Position: 176000.00
ICU balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
ICU balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1819000.00
ICU balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1819000.00
ICU balance_sheet (annual, 2024-12-31) — Cash Financial: 1819000.00
ICU cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 17650000.00
ICU cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -16007000.00
ICU cash_flow (annual, 2024-12-31) — Change In Account Payable: -1281000.00
ICU cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1875000.00
ICU cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
ICU cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 313000.00
ICU cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -100000.00
ICU cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -595000.00
ICU cash_flow (annual, 2024-12-31) — Change In Payable: -1281000.00
ICU cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 594000.00
ICU cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 297000.00
ICU cash_flow (annual, 2024-12-31) — Change In Receivables: -112000.00
ICU cash_flow (annual, 2024-12-31) — Change In Working Capital: 992000.00
ICU cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -112000.00
ICU cash_flow (annual, 2024-12-31) — Changes In Cash: 1643000.00
ICU balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
ICU balance_sheet (annual, 2024-12-31) — Common Stock Equity: -2183000.00
ICU cash_flow (annual, 2024-12-31) — Common Stock Issuance: 17441000.00
ICU income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
ICU balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3188000.00
ICU balance_sheet (annual, 2024-12-31) — Current Assets: 3766000.00
ICU balance_sheet (annual, 2024-12-31) — Current Debt: 574000.00
ICU balance_sheet (quarterly, 2024-12-31) — Current Debt: 574000.00
ICU balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 574000.00
ICU balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 574000.00
ICU balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
ICU balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
ICU balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
ICU balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
ICU balance_sheet (annual, 2024-12-31) — Current Liabilities: 6841000.00
ICU income_statement (annual, 2024-12-31) — Diluted Average Shares: 374355.00
ICU income_statement (annual, 2024-12-31) — Diluted EPS: -66.30
ICU income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -24830000.00
ICU income_statement (annual, 2024-12-31) — EBIT: -24583000.00
ICU income_statement (annual, 2024-12-31) — EBITDA: -24583000.00
ICU cash_flow (annual, 2024-12-31) — End Cash Position: 1819000.00
ICU cash_flow (annual, 2024-12-31) — Financing Cash Flow: 17650000.00
ICU cash_flow (annual, 2024-12-31) — Free Cash Flow: -16007000.00
ICU cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 697000.00
ICU cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -76000.00
ICU income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -697000.00
ICU income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 76000.00
ICU income_statement (annual, 2024-12-31) — General And Administrative Expense: 8872000.00
ICU balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 112000.00
ICU balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 112000.00
ICU income_statement (annual, 2024-12-31) — Gross Profit: 135000.00
ICU cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 3000.00
ICU income_statement (annual, 2024-12-31) — Interest Expense: 244000.00
ICU income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 244000.00
ICU income_statement (annual, 2024-12-31) — Interest Income: 101000.00
ICU income_statement (annual, 2024-12-31) — Interest Income Non Operating: 101000.00
ICU cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 553000.00
ICU balance_sheet (annual, 2024-12-31) — Inventory: 0.00
ICU balance_sheet (annual, 2024-12-31) — Invested Capital: -1609000.00
ICU cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 17441000.00
ICU cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1692000.00
ICU cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 713000.00
ICU cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1692000.00
ICU cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 713000.00
ICU cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -6102000.00
ICU cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -142000.00
ICU cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 17441000.00
ICU income_statement (annual, 2024-12-31) — Net Income: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -24830000.00
ICU cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -24830000.00
ICU income_statement (annual, 2024-12-31) — Net Interest Income: -143000.00
ICU cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -4410000.00
ICU cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -4410000.00
ICU cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 571000.00
ICU income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -143000.00
ICU balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -2183000.00
ICU income_statement (annual, 2024-12-31) — Normalized EBITDA: -23886000.00
ICU income_statement (annual, 2024-12-31) — Normalized Income: -24133000.00
ICU cash_flow (annual, 2024-12-31) — Operating Cash Flow: -16007000.00
ICU cash_flow (annual, 2024-12-31) — Operating Gains Losses: 697000.00
ICU cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -76000.00
ICU income_statement (annual, 2024-12-31) — Operating Income: -17842000.00
ICU income_statement (annual, 2024-12-31) — Operating Revenue: 135000.00
ICU balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 597724.00
ICU balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 574000.00
ICU balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 574000.00
ICU balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 33000.00
ICU income_statement (annual, 2024-12-31) — Other Gand A: 8872000.00
ICU income_statement (annual, 2024-12-31) — Other Income Expense: -6842000.00
ICU income_statement (quarterly, 2024-12-31) — Other Income Expense: 76000.00
ICU cash_flow (annual, 2024-12-31) — Other Non Cash Items: 102000.00
ICU balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 892000.00
ICU income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -6145000.00
ICU income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 0.00
ICU balance_sheet (annual, 2024-12-31) — Payables: 3046000.00
ICU balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6234000.00
ICU balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ICU balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1835000.00
ICU income_statement (annual, 2024-12-31) — Pretax Income: -24827000.00
ICU cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 4619000.00
ICU balance_sheet (annual, 2024-12-31) — Receivables: 112000.00
ICU income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
ICU cash_flow (annual, 2024-12-31) — Repayment Of Debt: -6102000.00
ICU income_statement (annual, 2024-12-31) — Research And Development: 9105000.00
ICU balance_sheet (annual, 2024-12-31) — Retained Earnings: -139564000.00
ICU income_statement (annual, 2024-12-31) — Selling General And Administration: 8872000.00
ICU balance_sheet (annual, 2024-12-31) — Share Issued: 597724.00
ICU income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
ICU income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
ICU cash_flow (annual, 2024-12-31) — Stock Based Compensation: 887000.00
ICU balance_sheet (annual, 2024-12-31) — Stockholders Equity: -2183000.00
ICU balance_sheet (annual, 2024-12-31) — Tangible Book Value: -2183000.00
ICU income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (annual, 2024-12-31) — Tax Provision: 3000.00
ICU income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ICU balance_sheet (annual, 2024-12-31) — Total Assets: 4658000.00
ICU balance_sheet (annual, 2024-12-31) — Total Capitalization: -2183000.00
ICU balance_sheet (annual, 2024-12-31) — Total Debt: 574000.00
ICU balance_sheet (quarterly, 2024-12-31) — Total Debt: 574000.00
ICU balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -2183000.00
ICU income_statement (annual, 2024-12-31) — Total Expenses: 17977000.00
ICU balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 6841000.00
ICU balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 892000.00
ICU balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -17842000.00
ICU income_statement (annual, 2024-12-31) — Total Unusual Items: -697000.00
ICU income_statement (quarterly, 2024-12-31) — Total Unusual Items: 76000.00
ICU income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -697000.00
ICU income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 76000.00
ICU cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 6145000.00
ICU cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
ICU balance_sheet (annual, 2024-12-31) — Working Capital: -3075000.00
ICU income_statement (quarterly, 2025-03-31) — +Operating Expense: 4115000.00
ICU income_statement (quarterly, 2025-03-31) — +Total Revenue: 293000.00
ICU balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3397000.00
ICU balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 110000.00
ICU balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 143899000.00
ICU income_statement (quarterly, 2025-03-31) — Basic Average Shares: 861793.00
ICU income_statement (quarterly, 2025-03-31) — Basic EPS: -4.40
ICU cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1819000.00
ICU balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
ICU balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5296000.00
ICU balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5296000.00
ICU balance_sheet (quarterly, 2025-03-31) — Cash Financial: 5296000.00
ICU cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 6131000.00
ICU cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2654000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 351000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 67000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Inventory: -44000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 79000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Payable: 351000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 418000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 501000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Receivables: 2000.00
ICU cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 956000.00
ICU cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 2000.00
ICU cash_flow (quarterly, 2025-03-31) — Changes In Cash: 3477000.00
ICU balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
ICU balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 565000.00
ICU cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1566000.00
ICU income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
ICU balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 3255000.00
ICU balance_sheet (quarterly, 2025-03-31) — Current Assets: 6784000.00
ICU balance_sheet (quarterly, 2025-03-31) — Current Debt: 363000.00
ICU balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 363000.00
ICU balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7032000.00
ICU income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 861793.00
ICU income_statement (quarterly, 2025-03-31) — Diluted EPS: -4.40
ICU income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — EBIT: -3758000.00
ICU income_statement (quarterly, 2025-03-31) — EBITDA: -3758000.00
ICU cash_flow (quarterly, 2025-03-31) — End Cash Position: 5296000.00
ICU cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 6131000.00
ICU cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2654000.00
ICU cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -16000.00
ICU income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 16000.00
ICU income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1684000.00
ICU income_statement (quarterly, 2025-03-31) — Gross Profit: 293000.00
ICU income_statement (quarterly, 2025-03-31) — Interest Expense: 11000.00
ICU income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 11000.00
ICU income_statement (quarterly, 2025-03-31) — Interest Income: 48000.00
ICU income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 48000.00
ICU cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
ICU balance_sheet (quarterly, 2025-03-31) — Inventory: 44000.00
ICU balance_sheet (quarterly, 2025-03-31) — Invested Capital: 928000.00
ICU cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1566000.00
ICU cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
ICU cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
ICU cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -222000.00
ICU cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1566000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3772000.00
ICU cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3772000.00
ICU income_statement (quarterly, 2025-03-31) — Net Interest Income: 37000.00
ICU cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -222000.00
ICU cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -222000.00
ICU income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 37000.00
ICU balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 565000.00
ICU income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3774000.00
ICU income_statement (quarterly, 2025-03-31) — Normalized Income: -3784640.00
ICU cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2654000.00
ICU cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -16000.00
ICU income_statement (quarterly, 2025-03-31) — Operating Income: -3822000.00
ICU income_statement (quarterly, 2025-03-31) — Operating Revenue: 293000.00
ICU balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 925776.00
ICU balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 363000.00
ICU balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 17000.00
ICU income_statement (quarterly, 2025-03-31) — Other Gand A: 1684000.00
ICU income_statement (quarterly, 2025-03-31) — Other Income Expense: 16000.00
ICU cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 11000.00
ICU balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 813000.00
ICU balance_sheet (quarterly, 2025-03-31) — Payables: 3397000.00
ICU balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6652000.00
ICU balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ICU balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1334000.00
ICU income_statement (quarterly, 2025-03-31) — Pretax Income: -3769000.00
ICU cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 4787000.00
ICU balance_sheet (quarterly, 2025-03-31) — Receivables: 110000.00
ICU income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00
ICU cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -222000.00
ICU income_statement (quarterly, 2025-03-31) — Research And Development: 2431000.00
ICU balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -143336000.00
ICU income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1684000.00
ICU balance_sheet (quarterly, 2025-03-31) — Share Issued: 925776.00
ICU cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 167000.00
ICU balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 565000.00
ICU balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 565000.00
ICU income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 3360.00
ICU income_statement (quarterly, 2025-03-31) — Tax Provision: 3000.00
ICU income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
ICU balance_sheet (quarterly, 2025-03-31) — Total Assets: 7597000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 565000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Debt: 363000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 565000.00
ICU income_statement (quarterly, 2025-03-31) — Total Expenses: 4115000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7032000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 813000.00
ICU balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3822000.00
ICU income_statement (quarterly, 2025-03-31) — Total Unusual Items: 16000.00
ICU income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 16000.00
ICU balance_sheet (quarterly, 2025-03-31) — Working Capital: -248000.00
ICU income_statement (quarterly, 2025-06-30) — +Operating Expense: 2067000.00
ICU income_statement (quarterly, 2025-06-30) — +Total Revenue: 338000.00
ICU balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3158000.00
ICU balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 217000.00
ICU balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 148677000.00
ICU balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -8000.00
ICU income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1132951.00
ICU income_statement (quarterly, 2025-06-30) — Basic EPS: -1.80
ICU cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5296000.00
ICU balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
ICU balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6302000.00
ICU balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6302000.00
ICU balance_sheet (quarterly, 2025-06-30) — Cash Financial: 6302000.00
ICU cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4013000.00
ICU cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3007000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -239000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -1372000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Inventory: -33000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 77000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Payable: -239000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1611000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 283000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Receivables: -107000.00
ICU cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1391000.00
ICU cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -107000.00
ICU cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1006000.00
ICU balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
ICU balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3341000.00
ICU cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 3588000.00
ICU income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 27000.00
ICU balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1883000.00
ICU balance_sheet (quarterly, 2025-06-30) — Current Assets: 7647000.00
ICU balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5042000.00
ICU balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 0.00
ICU income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1132951.00
ICU income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.80
ICU income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — EBIT: -1993000.00
ICU income_statement (quarterly, 2025-06-30) — EBITDA: -1993000.00
ICU cash_flow (quarterly, 2025-06-30) — End Cash Position: 6302000.00
ICU cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4013000.00
ICU cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3007000.00
ICU cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -16000.00
ICU income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 16000.00
ICU income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1030000.00
ICU balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 225000.00
ICU income_statement (quarterly, 2025-06-30) — Gross Profit: 311000.00
ICU income_statement (quarterly, 2025-06-30) — Interest Expense: 9000.00
ICU income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 9000.00
ICU income_statement (quarterly, 2025-06-30) — Interest Income: 45000.00
ICU income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 45000.00
ICU cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
ICU balance_sheet (quarterly, 2025-06-30) — Inventory: 77000.00
ICU balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3341000.00
ICU cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 3588000.00
ICU cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
ICU cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
ICU cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -370000.00
ICU cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 3588000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2002000.00
ICU cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2002000.00
ICU income_statement (quarterly, 2025-06-30) — Net Interest Income: -262000.00
ICU cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -370000.00
ICU cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -370000.00
ICU income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -262000.00
ICU balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3341000.00
ICU income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2009000.00
ICU income_statement (quarterly, 2025-06-30) — Normalized Income: -2018000.00
ICU cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3007000.00
ICU cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -16000.00
ICU income_statement (quarterly, 2025-06-30) — Operating Income: -1756000.00
ICU income_statement (quarterly, 2025-06-30) — Operating Revenue: 338000.00
ICU balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1734326.00
ICU balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1000.00
ICU income_statement (quarterly, 2025-06-30) — Other Gand A: 1030000.00
ICU income_statement (quarterly, 2025-06-30) — Other Income Expense: 16000.00
ICU cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 305000.00
ICU balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 736000.00
ICU balance_sheet (quarterly, 2025-06-30) — Payables: 3158000.00
ICU balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5041000.00
ICU balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ICU balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1051000.00
ICU income_statement (quarterly, 2025-06-30) — Pretax Income: -2002000.00
ICU cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 795000.00
ICU balance_sheet (quarterly, 2025-06-30) — Receivables: 217000.00
ICU income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 27000.00
ICU cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -370000.00
ICU income_statement (quarterly, 2025-06-30) — Research And Development: 1037000.00
ICU balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -145338000.00
ICU income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1030000.00
ICU balance_sheet (quarterly, 2025-06-30) — Share Issued: 1734326.00
ICU cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 97000.00
ICU balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3341000.00
ICU balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3341000.00
ICU income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
ICU income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Assets: 8383000.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3341000.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3341000.00
ICU income_statement (quarterly, 2025-06-30) — Total Expenses: 2094000.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5042000.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 736000.00
ICU balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1756000.00
ICU income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 298000.00
ICU income_statement (quarterly, 2025-06-30) — Total Unusual Items: 16000.00
ICU income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 16000.00
ICU balance_sheet (quarterly, 2025-06-30) — Working Capital: 2605000.00
ICU income_statement (quarterly, 2025-09-30) — +Operating Expense: 3748000.00
ICU income_statement (quarterly, 2025-09-30) — +Total Revenue: 183000.00
ICU balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2018000.00
ICU balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 221000.00
ICU balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 160271000.00
ICU balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -7000.00
ICU income_statement (quarterly, 2025-09-30) — Basic Average Shares: 2639340.00
ICU income_statement (quarterly, 2025-09-30) — Basic EPS: -1.30
ICU cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6302000.00
ICU balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3000.00
ICU balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 13763000.00
ICU balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 13763000.00
ICU balance_sheet (quarterly, 2025-09-30) — Cash Financial: 13763000.00
ICU cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 11305000.00
ICU cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -3844000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1140000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 164000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Inventory: -6000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 80000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Payable: -1140000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -976000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 244000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Receivables: -4000.00
ICU cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -662000.00
ICU cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -4000.00
ICU cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7461000.00
ICU balance_sheet (quarterly, 2025-09-30) — Common Stock: 3000.00
ICU balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 11464000.00
ICU cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 9183000.00
ICU income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 14000.00
ICU balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2047000.00
ICU balance_sheet (quarterly, 2025-09-30) — Current Assets: 14874000.00
ICU balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4066000.00
ICU balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 0.00
ICU income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 2639340.00
ICU income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.30
ICU income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — EBIT: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — EBITDA: -3472000.00
ICU cash_flow (quarterly, 2025-09-30) — End Cash Position: 13763000.00
ICU cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 11305000.00
ICU cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3844000.00
ICU cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
ICU income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1898000.00
ICU balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 228000.00
ICU income_statement (quarterly, 2025-09-30) — Gross Profit: 169000.00
ICU income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
ICU income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
ICU income_statement (quarterly, 2025-09-30) — Interest Income: 107000.00
ICU income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 107000.00
ICU cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
ICU balance_sheet (quarterly, 2025-09-30) — Inventory: 83000.00
ICU balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11464000.00
ICU cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 9183000.00
ICU cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
ICU cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 9183000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3472000.00
ICU cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Net Interest Income: 107000.00
ICU cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
ICU income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 107000.00
ICU balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 11464000.00
ICU income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3472000.00
ICU income_statement (quarterly, 2025-09-30) — Normalized Income: -3472000.00
ICU cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3844000.00
ICU cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
ICU income_statement (quarterly, 2025-09-30) — Operating Income: -3579000.00
ICU income_statement (quarterly, 2025-09-30) — Operating Revenue: 183000.00
ICU balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3409642.00
ICU balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1000.00
ICU income_statement (quarterly, 2025-09-30) — Other Gand A: 1898000.00
ICU cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 0.00
ICU balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 656000.00
ICU balance_sheet (quarterly, 2025-09-30) — Payables: 2018000.00
ICU balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4065000.00
ICU balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ICU balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 807000.00
ICU income_statement (quarterly, 2025-09-30) — Pretax Income: -3472000.00
ICU cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 2122000.00
ICU balance_sheet (quarterly, 2025-09-30) — Receivables: 221000.00
ICU income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 14000.00
ICU cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
ICU income_statement (quarterly, 2025-09-30) — Research And Development: 1850000.00
ICU balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -148810000.00
ICU income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1898000.00
ICU balance_sheet (quarterly, 2025-09-30) — Share Issued: 3409642.00
ICU cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 290000.00
ICU balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 11464000.00
ICU balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 11464000.00
ICU income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ICU income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
ICU income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Assets: 15530000.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 11464000.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 11464000.00
ICU income_statement (quarterly, 2025-09-30) — Total Expenses: 3762000.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4066000.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 656000.00
ICU balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
ICU income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3579000.00
ICU balance_sheet (quarterly, 2025-09-30) — Working Capital: 10808000.00
ICU income_statement (annual, 2025-12-31) — +Operating Expense: 13356000.00
ICU income_statement (quarterly, 2025-12-31) — +Operating Expense: 3424000.00
ICU income_statement (annual, 2025-12-31) — +Total Revenue: 1234000.00
ICU income_statement (quarterly, 2025-12-31) — +Total Revenue: 420000.00
ICU balance_sheet (annual, 2025-12-31) — Accounts Payable: 948000.00
ICU balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 948000.00
ICU balance_sheet (annual, 2025-12-31) — Accounts Receivable: 237000.00
ICU balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 237000.00
ICU balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 162126000.00
ICU balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 162126000.00
ICU balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICU balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICU income_statement (annual, 2025-12-31) — Basic Average Shares: 2073087.00
ICU income_statement (quarterly, 2025-12-31) — Basic Average Shares: 3621696.00